Related Experiment Videos
Adrenocortical carcinoma: clinical, morphologic, and molecular characterization
Alexander Stojadinovic1, Ronald A Ghossein, Axel Hoos
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Summary
Adrenocortical carcinoma (ACC) prognosis is linked to histologic features and molecular phenotypes. Patient-specific targeted therapy is crucial due to the complex and heterogeneous nature of ACC molecular profiles.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy.
- Understanding its molecular complexity is key to improving patient outcomes.
Purpose of the Study:
- To define multimolecular phenotypes of adrenocortical carcinoma (ACC).
- To correlate morphologic and molecular parameters with patient outcomes.
Main Methods:
- Analysis of clinical data from 124 patients.
- Histopathologic evaluation of 67 primary tumors and molecular expression profiling via immunohistochemistry.
- Correlation of morphologic and protein expression patterns with disease-specific survival (DSS) using statistical analysis.
Main Results:
- Significant predictors of DSS included distant metastasis, invasion, necrosis, mitotic rate, and mdm-2 overexpression.
- Five-year DSS decreased significantly with an increasing number of adverse histologic parameters.
- Molecular phenotypic expression was more heterogeneous in malignant ACC compared to normal adrenal tissue.
Conclusions:
- Morphologic evaluation, mitotic count, and tumor stage are essential for ACC prognosis.
- Multimolecular phenotyping reveals significant molecular heterogeneity, necessitating patient-specific targeted therapies.